256 related articles for article (PubMed ID: 25293590)
1. Pathways of cholesterol homeostasis in mouse retina responsive to dietary and pharmacologic treatments.
Zheng W; Mast N; Saadane A; Pikuleva IA
J Lipid Res; 2015 Jan; 56(1):81-97. PubMed ID: 25293590
[TBL] [Abstract][Full Text] [Related]
2. Cholesterol homeostasis in the retina: seeing is believing.
Fliesler SJ
J Lipid Res; 2015 Jan; 56(1):1-4. PubMed ID: 25421059
[No Abstract] [Full Text] [Related]
3. HMG-CoA reductase inhibitors, simvastatin and atorvastatin, downregulate ABCG1-mediated cholesterol efflux in human macrophages.
Wang W; Song W; Wang Y; Chen L; Yan X
J Cardiovasc Pharmacol; 2013 Jul; 62(1):90-8. PubMed ID: 23846804
[TBL] [Abstract][Full Text] [Related]
4. Retinal Cholesterol Content Is Reduced in Simvastatin-Treated Mice Due to Inhibited Local Biosynthesis Albeit Increased Uptake of Serum Cholesterol.
Mast N; Bederman IR; Pikuleva IA
Drug Metab Dispos; 2018 Nov; 46(11):1528-1537. PubMed ID: 30115644
[TBL] [Abstract][Full Text] [Related]
5. Regulation of bile acid, cholesterol, and fatty acid synthesis in chicken primary hepatocytes by different concentrations of T0901317, an agonist of liver X receptors.
Sato K; Kamada T
Comp Biochem Physiol A Mol Integr Physiol; 2011 Feb; 158(2):201-6. PubMed ID: 21056113
[TBL] [Abstract][Full Text] [Related]
6. Liver X receptor activation increases hepatic fatty acid desaturation by the induction of SCD1 expression through an LXRα-SREBP1c-dependent mechanism.
Zhang X; Liu J; Su W; Wu J; Wang C; Kong X; Gustafsson JÅ; Ding J; Ma X; Guan Y
J Diabetes; 2014 May; 6(3):212-20. PubMed ID: 23945440
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of steroidogenic acute regulatory protein increases macrophage cholesterol efflux to apolipoprotein AI.
Taylor JM; Borthwick F; Bartholomew C; Graham A
Cardiovasc Res; 2010 Jun; 86(3):526-34. PubMed ID: 20083572
[TBL] [Abstract][Full Text] [Related]
8. Feedback modulation of cholesterol metabolism by the lipid-responsive non-coding RNA LeXis.
Sallam T; Jones MC; Gilliland T; Zhang L; Wu X; Eskin A; Sandhu J; Casero D; Vallim TQ; Hong C; Katz M; Lee R; Whitelegge J; Tontonoz P
Nature; 2016 Jun; 534(7605):124-8. PubMed ID: 27251289
[TBL] [Abstract][Full Text] [Related]
9. The E3 ubiquitin ligase IDOL induces the degradation of the low density lipoprotein receptor family members VLDLR and ApoER2.
Hong C; Duit S; Jalonen P; Out R; Scheer L; Sorrentino V; Boyadjian R; Rodenburg KW; Foley E; Korhonen L; Lindholm D; Nimpf J; van Berkel TJ; Tontonoz P; Zelcer N
J Biol Chem; 2010 Jun; 285(26):19720-6. PubMed ID: 20427281
[TBL] [Abstract][Full Text] [Related]
10. Fetal liver X receptor activation acutely induces lipogenesis but does not affect plasma lipid response to a high-fat diet in adult mice.
van Straten EM; van Meer H; Huijkman NC; van Dijk TH; Baller JF; Verkade HJ; Kuipers F; Plösch T
Am J Physiol Endocrinol Metab; 2009 Nov; 297(5):E1171-8. PubMed ID: 19724022
[TBL] [Abstract][Full Text] [Related]
11. Liver X Receptor Agonist TO901317 Prevents Diacylglycerols Accumulation in the Heart of Streptozotocin-Diabetic Rats.
Harasiuk D; Baranowski M; Zabielski P; Chabowski A; Górski J
Cell Physiol Biochem; 2016; 39(1):350-9. PubMed ID: 27352290
[TBL] [Abstract][Full Text] [Related]
12. Studies of ApoD
El-Darzi N; Mast N; Petrov AM; Dao T; Astafev AA; Saadane A; Prendergast E; Schwarz E; Bederman I; Pikuleva IA
Cell Mol Life Sci; 2021 Feb; 78(3):963-983. PubMed ID: 32440710
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological LXR activation reduces presence of SR-B1 in liver membranes contributing to LXR-mediated induction of HDL-cholesterol.
Grefhorst A; Oosterveer MH; Brufau G; Boesjes M; Kuipers F; Groen AK
Atherosclerosis; 2012 Jun; 222(2):382-9. PubMed ID: 22481067
[TBL] [Abstract][Full Text] [Related]
14. Activation of liver X receptor decreases atherosclerosis in Ldlr⁻/⁻ mice in the absence of ATP-binding cassette transporters A1 and G1 in myeloid cells.
Kappus MS; Murphy AJ; Abramowicz S; Ntonga V; Welch CL; Tall AR; Westerterp M
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):279-84. PubMed ID: 24311381
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological activation of LXRs decreases amyloid-β levels in Niemann-Pick type C model cells.
Stefulj J; Peric M; Malnar M; Kosicek M; Schweinzer C; Zivkovic J; Scholler M; Panzenboeck U; Hecimovic S
Curr Pharm Biotechnol; 2013; 14(6):582-93. PubMed ID: 24016269
[TBL] [Abstract][Full Text] [Related]
16. Liver X receptors regulate cholesterol homeostasis in oligodendrocytes.
Nelissen K; Mulder M; Smets I; Timmermans S; Smeets K; Ameloot M; Hendriks JJ
J Neurosci Res; 2012 Jan; 90(1):60-71. PubMed ID: 21972082
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological activation of LXR in utero directly influences ABC transporter expression and function in mice but does not affect adult cholesterol metabolism.
van Straten EM; Huijkman NC; Baller JF; Kuipers F; Plösch T
Am J Physiol Endocrinol Metab; 2008 Dec; 295(6):E1341-8. PubMed ID: 18840761
[TBL] [Abstract][Full Text] [Related]
18. Identification of a novel partial agonist of liver X receptor α (LXRα) via screening.
Li N; Wang X; Zhang J; Liu C; Li Y; Feng T; Xu Y; Si S
Biochem Pharmacol; 2014 Dec; 92(3):438-47. PubMed ID: 25450668
[TBL] [Abstract][Full Text] [Related]
19. Feedback regulation of cholesterol uptake by the LXR-IDOL-LDLR axis.
Zhang L; Reue K; Fong LG; Young SG; Tontonoz P
Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2541-6. PubMed ID: 22936343
[TBL] [Abstract][Full Text] [Related]
20. Liver X receptors alpha and beta promote myelination and remyelination in the cerebellum.
Meffre D; Shackleford G; Hichor M; Gorgievski V; Tzavara ET; Trousson A; Ghoumari AM; Deboux C; Nait Oumesmar B; Liere P; Schumacher M; Baulieu EE; Charbonnier F; Grenier J; Massaad C
Proc Natl Acad Sci U S A; 2015 Jun; 112(24):7587-92. PubMed ID: 26023184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
